Intermediate tumor cells and exhausted CD8+ T cells were both significantly enriched in immunotherapy untreated samples compared to immunotherapy-resistant samples in the scRNA-seq dataset (Figure 7F, chi-squared test, intermediate p = 1.41e-64, exhausted p = 0.00334). This evidence concerns the gene CD8A and neoplasm.